Statera BioPharma Inc (STAB)
0.0007
0.00 (0.00%)
USD |
OTCM |
May 07, 12:37
Statera BioPharma Cash from Operations (TTM): -12.09M for Sept. 30, 2022
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
September 30, 2022 | -12.09M |
June 30, 2022 | -26.51M |
Date | Value |
---|---|
March 31, 2022 | -29.36M |
December 31, 2021 | -28.19M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-29.36M
Minimum
Mar 2022
-12.09M
Maximum
Sep 2022
-24.04M
Average
-27.35M
Median
Cash from Operations (TTM) Benchmarks
Humanigen Inc | -64.32M |
Cantabio Pharmaceuticals Inc | -0.7984M |
Affymax Inc | -- |
RVL Pharmaceuticals PLC | -44.41M |
Scopus BioPharma Inc | -3.043M |